CHEK2*1100delC and male breast cancer risk in Israel
- 28 October 2003
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 108 (3), 479-480
- https://doi.org/10.1002/ijc.11603
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast CancerAmerican Journal of Human Genetics, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- Male breast carcinoma in IsraelCancer, 2002
- Male breast cancer in Cowden syndrome patients with germline PTEN mutationsJournal of Medical Genetics, 2001
- Genetic Analyses of Male Breast Cancer in IsraelGenetic Testing, 2000
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- BRCA2 germline mutations in male breast cancer cases and breast cancer familiesNature Genetics, 1996
- Androgen receptor gene mutation in male breast cancerHuman Molecular Genetics, 1993
- Review article: Epidemiology of male breast cancer. A meta‐analysis of published case‐control studies and discussion of selected aetiological factorsInternational Journal of Cancer, 1993
- A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndromeNature Genetics, 1992